NCT03646409View on ClinicalTrials.gov

Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer

CompletedOBSERVATIONAL
Enrollment

542

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

December 1, 2018

Conditions
Venous ThromboembolismEsophagus CancerBleedingChemotherapy Effect
Interventions
OTHER

Venous thromboembolic event, arterial thromboembolic event, bleeding events

Whether or not venous or arterial thromboembolic and bleeding events occur in patients with esophageal cancer receiving neoadjuvant chemotherapy

Trial Locations (1)

1105 AZ

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03646409 - Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer | Biotech Hunter | Biotech Hunter